These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4002790)

  • 1. Food and muzolimine interaction.
    Ritter W; Wingender W; Hanisch M; Lietz U
    Z Kardiol; 1985; 74 Suppl 2():145-8. PubMed ID: 4002790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of muzolimine after oral administration with and without aluminium hydroxide in healthy volunteers.
    Ritter W; Hanisch M; Lücker PW; Venitz F; Hey B; Baykal N
    Z Kardiol; 1985; 74 Suppl 2():149-51. PubMed ID: 4002791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
    Loew D; Dýcka J; Pfleiderer T; Ritter W
    Z Gastroenterol; 1980 Oct; 18(10):537-42. PubMed ID: 7456563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of captopril bioavailability by concomitant food and antacid intake.
    Mäntylä R; Männistö PT; Vuorela A; Sundberg S; Ottoila P
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):626-9. PubMed ID: 6389377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic and pharmacokinetic correlation of muzolimine with and without aluminium hydroxide.
    Lücker PW; Venitz J; Hey B; Baykal N; Hanisch M; Ritter W
    Z Kardiol; 1985; 74 Suppl 2():141-4. PubMed ID: 4002789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
    Pargal A; Kelkar MG; Nayak PJ
    Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of muzolimine in chronic heart failure.
    Storstein L; Bjørnstad H; Mølstad P
    Z Kardiol; 1985; 74 Suppl 2():34-6. PubMed ID: 4002802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of vinpocetine and interference of the time of application with food intake.
    Lohmann A; Dingler E; Sommer W; Schaffler K; Wober W; Schmidt W
    Arzneimittelforschung; 1992 Jul; 42(7):914-7. PubMed ID: 1418055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The bioavailability of enteric coated diclofenac formulations. 2. Bioavailability following single administration of a multiple-unit formulation in comparison to a single-unit formulation under fasting and non-fasting conditions].
    Scheidel B; Blume H; Walter K; Stanislaus F; Babej-Dölle RM
    Arzneimittelforschung; 1994 Apr; 44(4):544-50. PubMed ID: 8011009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake.
    Liedholm H; Lidén A; Kroon L; Melander A; Wåhlin-Boll E
    Drug Nutr Interact; 1985; 3(2):87-92. PubMed ID: 3987521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haemodialysis on the pharmacokinetics of muzolimine.
    Fiegel P; Röckel A; Hanisch M; Ritter W; Abdelhamid S; Walb D
    Z Kardiol; 1985; 74 Suppl 2():100-2. PubMed ID: 4002781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of muzolimine after acute and chronic dosing in hypertensive patients with mild renal insufficiency.
    Mann J; Ritter W; Heckmann N; Sörgel F; Ritz E
    Z Kardiol; 1985; 74 Suppl 2():77-9. PubMed ID: 4002808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability: influence of various diets on the bioavailability of indomethacin.
    Wallusch WW; Nowak H; Leopold G; Netter KJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):40-4. PubMed ID: 631970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on the pharmacokinetics of a new multiple unit sustained release sodium valproate formulation.
    Retzow A; Vens-Cappell B; Wangemann M
    Arzneimittelforschung; 1997 Dec; 47(12):1347-50. PubMed ID: 9450162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of single doses of muzolimine upon urinary solute and fluid excretion.
    Leary WP; Reyes AJ; van der Byl K
    Z Kardiol; 1985; 74 Suppl 2():135-40. PubMed ID: 4002788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
    Heinig R; Sachse R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of food and repeated dosing on the bioavailability of indomethacin from a multiple-units controlled-release formulation.
    Skinhøj A; Bechgaard H; Chasseaud LF; Brodie RR; Sharman JM; Taylor T; Hunter JO
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):557-61. PubMed ID: 6511132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of oxazepam: absence of influence of food intake.
    Melander A; Danielson K; Vessman J; Wählin E
    Acta Pharmacol Toxicol (Copenh); 1977 May; 40(5):584-8. PubMed ID: 577372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.